Navigation Links
Pasteuria Bioscience Receives EPA Registration for Nematode Control
Date:6/8/2009

ALACHUA, Fla., June 8 /PRNewswire/ -- Pasteuria Bioscience announced that it has received registration from the United States Environmental Protection Agency (EPA) for Pasteuria usgae. This is a critical step towards the commercial use of Pasteuria spp., a natural bacteria prevalent in soil that have long been recognized as promising biological control agents for plant-parasitic nematodes.

"We're very pleased to receive this EPA registration," said David Duncan, Ph.D., chief executive officer for Pasteuria Bioscience. "It confirms Pasteuria usgae as a safe, effective and an environmentally-friendly agent for sting nematode control."

Pasteuria spp. was first discovered over 50 years ago and identified as an effective agent for nematode control. Scientists have considered Pasteuria to be among the most promising biological agents for control of plant-parasitic nematodes, but until recently, no one was able to grow Pasteuria outside of the body of a nematode. Thus, it could not be produced cost-effectively on a commercial scale. Pasteuria Bioscience has developed a revolutionary new technology that allows the rapid and cost-effective growth of multiple strains of Pasteuria manufactured through traditional fermentation methods.

The Society of Nematology and other organizations estimate global crop losses due to nematodes at $100 billion annually making it agriculture's largest unmet pest control need. With current nematicides being voluntarily removed from the market due to safety and environmental concerns, few nematicide options exist to meet this demand. The registration of Pasteuria spp. is important in offering environmentally safe, cost-effective and reliable nematode control products helping to fill the niches that will be vacated by current nematicides.

With a robust pipeline of product candidates based on Pasteuria technology, this registration is the first of many to come. P. usgae is a highly efficacious biological nematicide and will be targeted for control of sting nematode in the golf, sports turf and landscape markets.

"This first step is important for Pasteuria Bioscience and serves as validation of the credibility of Pasteuria-derived products. We're confident about the future of this technology as an important tool to help growers control nematodes in a variety of crops and regions of world," said Duncan.

About Pasteuria Bioscience

Pasteuria Bioscience, Inc. was founded in 2003 in the University of Florida's Sid Martin Biotechnology Incubator. The company was developed out of Entomos, Inc., to commercialize its revolutionary technology for production of nematode control products based on Pasteuria technology.

Pasteuria Bioscience is developing products based on Pasteuria spp. to treat major nematode pests in most agricultural crops. Its first product will provide sting nematode control for the golf and sports turf markets. Subsequent products will offer nematode control in agronomic crops such as soybean and cotton, in specialty crops such as strawberry and banana; and in vegetables.

Pasteuria Bioscience continues to build its pipeline of products and its intellectual property portfolio through a vigorous development program.

For more information, visit the Pasteuria Bioscience web site at http://www.pasteuriabio.com.


'/>"/>
SOURCE Pasteuria Bioscience
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Pasteuria Bioscience Taps New CEO David N. Duncan
2. Neurocrine Biosciences to Present at the 8th Annual Needham Life Sciences Conference
3. EUCODIS Bioscience Launches Beta-Lactamase for Antibiotics and Diagnostics Industries
4. Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
5. Regado Biosciences Establishes Medical Advisory Board
6. New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the Worlds Leading Bioenergetics Researchers
7. YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING
8. EUCODIS Bioscience Signs Research Agreement With Genencor
9. Universite de Montreal and Validapro Biosciences Inc. have Signed an Agreement-in-Principle
10. YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
11. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Worcester, Mass. (PRWEB) , ... March 22, 2017 ... ... to scale up human tissue regeneration from small lab samples to full-size tissues, ... injuries: how to establish a vascular system that delivers blood deep into the ...
(Date:3/22/2017)... , March 22, 2017  UBM and ... to announce their extended partnership and the third ... headlined by the 21 st Annual MassMEDIC ... taking place May 3-4, 2017. ... Technology Association (ADVAMED) President and CEO, Scott ...
(Date:3/22/2017)... March 22, 2017 Oramed Pharmaceuticals Inc. ... www.oramed.com ), a clinical-stage pharmaceutical ... delivery systems, announced today that Dr. Miriam ... a presentation titled, "Oral Insulin for Diabetes Treatment: ... Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... March 22, 2017 The global ... a research report by Transparency Market Research (TMR). The ... Inc., and AbbVie Inc., accounted for a share of ... players in this market are focusing aggressively on mergers, ... which is likely to lead to market consolidation in ...
Breaking Biology Technology:
(Date:2/24/2017)... Spain , Feb. 24, 2017  EyeLock LLC, a ... demonstrate its elite iris biometric solution on the ... X16 LTE at Mobile World Congress 2017 ... Qualcomm,s Booth in Hall 3, Stand 3E10. ... the Qualcomm Haven™ security platform—a combination of ...
(Date:2/16/2017)... FRANCISCO , Feb. 16, 2017  Genos, ... today announced that it has received Laboratory Accreditation ... CAP Accreditation is presented to laboratories that meet ... who demonstrate scientifically rigorous processes. "Genos ... excellence in laboratory practices. We,re honored to be ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
Breaking Biology News(10 mins):